(Q42615450)

3 November 2017

1 reference

title

Gastric cancer: clinical aspects, epidemiology and molecular background (English)

1 reference

3 November 2017

1 reference

4

Peter Malfertheiner

1 reference

3 November 2017

Jan Bornschein

1

1 reference

3 November 2017

Theodore Rokkas

series ordinal

2

1 reference

3 November 2017

Michael Selgrad

series ordinal

3

1 reference

3 November 2017

publication date

1 September 2011

1 reference

3 November 2017

1 reference

3 November 2017

volume

16 Suppl 1

1 reference

3 November 2017

page(s)

45-52

1 reference

Evaluation of the Seventh American Joint Committee on Cancer/International Union Against Cancer Classification of gastric adenocarcinoma in comparison with the sixth classification

3 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

EUS for the staging of gastric cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Effectiveness and safety of oxaliplatin compared to cisplatin for advanced, unresectable gastric cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Capecitabine for the treatment of advanced gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Irinotecan-involved regimens for advanced gastric cancer: a pooled-analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Salt intake and gastric cancer risk according to Helicobacter pylori infection, smoking, tumour site and histological type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Alcohol and tobacco use in relation to gastric cancer: a prospective study of men in Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Tobacco smoking and esophageal and gastric cardia adenocarcinoma: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Increased consumption of fruit and vegetables and future cancer incidence in selected European countries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Fish consumption and the risk of gastric cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Helicobacter pylori, nutrition and smoking interactions: their impact in gastric carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Prospective study of physical activity and risk of primary adenocarcinomas of the oesophagus and stomach in the EPIC (European Prospective Investigation into Cancer and nutrition) cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Aspirin use and the risk of gastric cancer: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Meta-analysis on the relationship between nonsteroidal anti-inflammatory drug use and gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Relationship between H.Pylori infection and clinicopathological features and prognosis of gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Changes in the prevalence of Helicobacter pylori infection and gastrointestinal diseases in the past 17 years.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

H. pylori Infection Is a Key Risk Factor for Proximal Gastric Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Helicobacter pylori infection and gastric cardia cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Gastric atrophy and risk of oesophageal cancer and gastric cardia adenocarcinoma--a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Autofluorescence imaging for predicting development of metachronous gastric cancer after Helicobacter pylori eradication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Gastritis staging in clinical practice: the OLGA staging system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Cost-effectiveness of endoscopic surveillance for gastric intestinal metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Cost-effectiveness of endoscopic surveillance of gastric ulcers to improve survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Prevalence of atrophic gastritis in dyspeptic patients in Piedmont. A survey using the GastroPanel test

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Polymorphisms in inflammatory response genes and their association with gastric cancer: A HuGE systematic review and meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Interleukin-1B and interleukin-1 RN polymorphisms and gastric carcinoma risk: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Helicobacter pylori dupA and gastric acid secretion are negatively associated with gastric cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Gene expression changes in patient-matched gastric normal mucosa, adenomas, and carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Helicobacter pylori infection promotes methylation and silencing of trefoil factor 2, leading to gastric tumor development in mice and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Helicobacter pylori CagA targets gastric tumor suppressor RUNX3 for proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

SOX2 in gastric carcinoma, but not Hath1, is related to patients' clinicopathological features and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Helicobacter pylori induction of the gastrin promoter through GC-rich DNA elements

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

CDX2 autoregulation in human intestinal metaplasia of the stomach: impact on the stability of the phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

The detection of Helicobacter pylori cag pathogenicity islands (PAIs) and expression of matrix metalloproteinase-7 (MMP-7) in gastric epithelial dysplasia and intramucosal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Gastric adenocarcinoma and Helicobacter pylori: correlation with p53 mutation and p27 immunoexpression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Regulation of p53 tumor suppressor by Helicobacter pylori in gastric epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

Involvement of tumor necrosis factor-alpha in the upregulation of CXCR4 expression in gastric cancer induced by Helicobacter pylori

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1523-5378.2011.00880.X

10.1111/J.1523-5378.2011.00880.X

21 January 2018

Identifiers

DOI

1 reference

3 November 2017

1 reference